EXE TOR Week ended 07 Aug 2026

Weekly Investor Report

Extendicare Inc. · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 32.44 CAD
-8.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 7.8% above the Trend Line and sits at 75.1% of its 52-week range. The latest completed week returned -8.6%, after a -12.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 49/100.

Setup score 67 out of 100
Latest Close 32.44 CAD 7 Aug 2026
1W Return -8.6% latest completed week
4W Return -12.2% short-term follow-through
12W Return -2.4% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 1.9x vs 13-week average
What is working
  • The trend backdrop is active with a 45-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 17 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -8.6% Latest completed week; four-week move -12.2%. Indicator stack 95/55 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 58.87% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 49/100 9 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.8% above the Trend Line and sits at 75.1% of its 52-week range. The latest completed week returned -8.6%, after a -12.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8312-week average 0.94

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.83Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1717 reversal markers

No recent accumulation markers. 17 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -12.2% over four weeks, -2.4% over 12 weeks, and 151.5% over one year. The current trend has remained active for 45 consecutive weeks.

Performance by holding period

1W-8.6%
4W-12.2%
12W-2.4%
26W36.1%
52W151.5%
Active trend streak45 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.53Latest activity-pressure read.
Pressure change-58.9%Four-week change in activity pressure.
Leadership19.55Latest relative-leadership reading.
RS change-60.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength60/100Blend of value, momentum, and quality. Underlying universe rank 41; rank 1 is best.
Value19/100Relative valuation strength. Underlying universe rank 82; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth73/100Revenue and earnings growth. Underlying universe rank 28; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework60/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
25.1x
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
14.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
8.8%
Operating profit retained from revenue.
Free-cash-flow margin
5.0%
Free cash flow generated from revenue.
Return on invested capital
29.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.2%
Latest one-year revenue growth.
EPS growth
13.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
2.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.6%
Cash dividends relative to market value.
Buyback yield
-6.2%
Net share repurchases relative to market value.
Shareholder yield
-4.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 9 relevant articles.

3 positive · 5 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.0%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+10.8%Week of 8 May.
Worst week-8.6%Week of 7 Aug.
Latest week-8.6%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains7
Flat weeks0
Modest losses8
Sharp losses3
Recent vol4.3%13-week weekly-return volatility.
Base vol4.9%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape75/100

Trend, activity pressure, participation, and risk combine to a 75/100 tape read.

 Indicator analysis80/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.83; 17 reversal markers Next-Week ExpectancyPositive 58.87%

Next-week expectancy is positive with a 58.87% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors64/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 88; Small Cap Core rank 86 SVQF60/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 123.5 of 304 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 9 relevant articles.

Extendicare Inc. (TSX:EXE) Stock Declines 5.12% as Healthcare Cost Pressures and Investor Caution Weigh on Outlook Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202632.44 CAD-8.6%30.10 CAD14.01 CAD0.5319.553.3MOn
31 Jul 202635.48 CAD-6.3%29.75 CAD13.84 CAD1.0736.542.5MOn
24 Jul 202637.86 CAD-2.3%29.26 CAD13.65 CAD1.4047.292.2MOn
17 Jul 202638.74 CAD4.8%28.70 CAD13.45 CAD1.3153.711.6MOn
10 Jul 202636.96 CAD-1.0%28.14 CAD13.24 CAD1.2949.001.4MOn
3 Jul 202637.31 CAD5.9%27.64 CAD13.05 CAD1.0853.08240.2KOn
26 Jun 202635.23 CAD4.2%27.14 CAD12.85 CAD0.9647.97438.7KOn
19 Jun 202633.80 CAD3.5%26.64 CAD12.66 CAD1.0144.034.6MOn
12 Jun 202632.64 CAD-1.4%26.18 CAD12.48 CAD1.0641.04298.3KOn
5 Jun 202633.10 CAD2.2%25.74 CAD12.31 CAD1.3446.96404.5KOn
29 May 202632.39 CAD-4.3%25.17 CAD12.14 CAD1.5944.181.6MOn
22 May 202633.83 CAD1.8%24.62 CAD11.97 CAD1.6153.711.8MOn
15 May 202633.23 CAD-0.4%24.02 CAD11.80 CAD1.5055.932.2MOn
8 May 202633.35 CAD10.8%23.41 CAD11.62 CAD1.3957.442.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context